RHÖN-KLINIKUM Aktiengesellschaft (FRA:RHK)

Germany flag Germany · Delayed Price · Currency is EUR
12.80
-0.20 (-1.54%)
At close: Feb 20, 2026
Market Cap876.89M -10.3%
Revenue (ttm)1.95B +6.4%
Net Income38.11M -15.1%
EPS0.57 -14.9%
Shares Outn/a
PE Ratio23.01
Forward PE20.63
Dividend0.10 (0.78%)
Ex-Dividend DateJun 4, 2025
Volumen/a
Average Volumen/a
Open12.80
Previous Close13.00
Day's Range12.80 - 12.80
52-Week Range11.20 - 15.90
Betan/a
RSI46.80
Earnings DateMar 26, 2026

About FRA:RHK

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company also operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany. [Read more]

Industry Hospitals
Founded 1973
Employees 19,041
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol RHK
Full Company Profile

Financial Performance

In 2024, FRA:RHK's revenue was 1.87 billion, an increase of 7.67% compared to the previous year's 1.73 billion. Earnings were 43.35 million, an increase of 11.98%.

Financial Statements

News

EQS-PVR: RHÖN-KLINIKUM AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: RHÖN-KLINIKUM Aktiengesellschaft RHÖN-KLINIKUM AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Euro...

2 days ago - Wallstreet:Online

EQS-AFR: RHÖN-KLINIKUM AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: RHÖN-KLINIKUM Aktiengesellschaft / Preliminary announcement on the disclosure of financial statements RHÖN-KLINIKUM AG: Preliminary announcement of the ...

3 days ago - Wallstreet:Online

RHÖN-KLINIKUM Adjusts 2025 EBITDA Forecast: What Investors Need to Know

RHÖN-KLINIKUM AG revises its 2025 outlook, trimming EBITDA expectations as rising costs and delayed refinancing effects weigh on the healthcare group’s performance.

5 weeks ago - Wallstreet:Online

EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft adjusts the EBITDA forecast for financial year 2025

EQS-Ad-hoc: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Change in Forecast RHÖN-KLINIKUM Aktiengesellschaft adjusts the EBITDA forecast for financial year 2025 14-Jan-2026 / 16:52 CET/CEST Disclos...

5 weeks ago - Wallstreet:Online

Rhoen-Klinikum Shines in H1 2025 with Strong Performance

RHÖN-KLINIKUM AG showcases resilience with a 7.5% revenue rise, navigating challenges with a focus on digital transformation and strategic partnerships. Jetzt den vollständigen Artikel lesen

7 months ago - Wallstreet:Online